Modulation of gut microbiota by foods and herbs to prevent cardiovascular diseases

Suraphan Panyod ； Wei-Kai Wu ； Chieh-Chang Chen ； Ming-Shiang Wu ； Chi-Tang Ho ； Lee-Yan Sheen

《Journal of Traditional and Complementary Medicine》 13卷2期 (2023/03) Pp. 107-118

https://doi.org/10.1016/j.jtcme.2021.09.006

摘要

Dietary nutrients are associated with the development of cardiovascular disease (CVD) both through traditional pathways (inducing hyperlipidemia and chronic inflammation) and through the emergence of a metaorganism-pathogenesis pathway (through the gut microbiota, its metabolites, and host). Several molecules from food play an important role as CVD risk-factor precursors either themselves or through the metabolism of the gut microbiome. Animal-based dietary proteins are the primary source of CVD risk-factor precursors; however, some plants also possess these precursors, though at relatively low levels compared with animal-source food products. Various medications have been developed to treat CVD through the gut-microbiota-circulation axis, and they exhibit potent effects in CVD treatment. Nevertheless, such medicines are still being improved, and there are many research gaps that need to be addressed. Furthermore, some medications have unpleasant or adverse effects. Numerous foods and herbs impart beneficial effects upon health and disease. In the past decade, many studies have focused on treating and preventing CVD by modulating the gut microbiota and their metabolites. This review provides an overview of the available information, summarizes current research related to the gut-microbiota-heart axis, enumerates the foods and herbs that are CVD-risk precursors, and illustrates how metabolites become CVD risk factors through the metabolism of gut microbiota. Moreover, we present perspectives on the application of foods and herbs-including prebiotics, probiotics, synbiotics, post-biotics, and antibiotic-like substances-as CVD prevention agents to modulate gut microbiota by inhibiting gut-derived CVD risk factors. Taxonomy (classification by EVISE): Cardiovascular disease, gut microbiota, herbal medicine, preventive medicine, dietary therapy, nutrition supplements.

關鍵字

Gut microbiota ； Microbial metabolite ； Cardiovascular disease ； Food ； Herbs

參考文獻

Lee-Yan S, Suraphan P, Wei-Kai W, et al. Atherosclerosis amelioration by allicin in raw garlic through gut microbiota and trimethylamine-N-oxide modulation. Research Square. 2021. https://doi.org/10.21203/rs.3.rs-519786/v1

Sorrenti V, Ali S, Mancin L, Davinelli S, Paoli A, Scapagnini G. Cocoa polyphenols and gut microbiota interplay: bioavailability, prebiotic effect, and impact on human health. Nutrients. 2020;12(7).

Cardona F, Andres-Lacueva C, Tulipani S, Tinahones FJ, Queipo-Ortuno MI. Benefits of polyphenols on gut microbiota and implications in human health. J Nutr Biochem. 2013;24(8):1415-1422.

Li Q, Gao B, Siqin B, et al. Gut microbiota: a novel regulator of cardiovascular disease and Key factor in the therapeutic effects of Flavonoids. Front Pharmacol. 2021;12:651926.

Liu YC, Li XY, Shen L. Modulation effect of tea consumption on gut microbiota. Appl Microbiol Biotechnol. 2020;104(3):981-987.